A recent gift from Valerie A. Trotman will support the CCC’s PsychOncology Program. The Alexander J. and Valerie A. Trotman Cancer Support Fund will enable a wide variety of support services to those undergoing cancer treatment at Michigan.
The University of Michigan Health System has begun offering a new urine test called Mi-Prostate Score to improve on PSA screening for prostate cancer.
The capturing of circulating cancer cells for DNA analysis has become a significant new tool in cancer treatment. The information these cells contain helps to fine-tune treatment plans -- and aids doctors in understanding if those treatments are working.
Adrenal cancer researchers at the University of Michigan Comprehensive Cancer Center are seeing the results of their laboratory studies translate to a clinical trial that will test a potential new therapy in patients with the disease.
University of Michigan Comprehensive Cancer Center Deputy Director Eric R. Fearon, M.D., Ph.D., was elected to the Washington, D.C.-based Institute of Medicine (IOM) of the National Academies.
On October 18 in Detroit's Cadillac Square, three colors made history when the U-M Health System, together with Catherine and Nate Forbes of the Forbes Company and Somerset Collection, hosted the first-ever Maize and Blue Go Pink benefit for breast cancer research at the Cancer Center.
Max Wicha, M.D., Director of the University of Michigan Comprehensive Cancer Center welcomes readers to the Winter, 2014 issue of MCancerNews.